FDA
-
-
-
-
-
-
-
Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing
-
-
-
-
-
-
-
Predictive Oncology Appoints Leading Biopharma Executive Matthew J. Hawryluk Ph.D. to the Board of Directors
-
-
-
-
-
-
-
Predictive Oncology validates Discovery 21 proof-of-concept campaign
-
-
-
-
-
-
-
Predictive Oncology Inc. Announces Newest Board Member
-
-
-
-
-
-
-
Predictive Oncology subsidiary, Helomics uses data from the 100,000 Genomes Project to better predict ovarian cancer outcomes
-
-
-
-
-
-
-
Predictive Oncology Inc. (POAI) Announces $21.34 Million Registered Direct Offering of Common Stock, Warrants
-
-
-
-
-
-
-
Predictive Oncology Reports Financial Results for Quarter Ended March 31, 2021 and Provides Business Update
-
322,971 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

